Health
FDA schedules meeting to discuss emergency use authorization of COVID-19 vaccine from Pfizer – News-Medical.Net
The U.S. Food and Drug Administration has scheduled a meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Dec. 10 to discuss…
Reviewed by Emily Henderson, B.Sc.Nov 23 2020
The U.S. Food and Drug Administration has request for emergency use authorization a meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Dec. 10 to discuss the request for emergency use authorization (EUA) of a COVID-19 vaccine from Pfizer, Inc. in partnership with BioNTech Manufacturing GmbH.
The FDA recognizes that transparency and dialogue are critical for the public to have confidence in COVID-19 vaccines. I want…
-
Noosa News21 hours agoCrucial step in Sea World helicopter crash investigation set
-
Business21 hours agoWhy Accent, DroneShield, EBR Systems, and Titomic shares are pushing higher
-
General17 hours agoForget a tariff-induced recession, Australians have been in recession for two years
-
Noosa News23 hours agoOne person found dead after early morning blaze guts family home near Toowoomba